← Scroll for more →
Stoke Therapeutics, Inc. (STOK)
Pharmaceutical Preparations
Latest Price
$26.29
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
5.55
P/B Ratio
4.74
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.88M | $192.0M | 9.42% | +491.6K | 2026-06-30 |
| Rtw Investments, LP | 5.62M | $184.0M | 9.01% | -- | 2026-06-30 |
| FMR LLC | 5.31M | $173.0M | 8.51% | -70.6K | 2026-06-30 |
| Lynx1 Capital Management LP | 4.04M | $132.0M | 6.47% | -725.3K | 2026-06-30 |
| Redmile Group, LLC | 3.95M | $129.0M | 6.32% | -218.2K | 2026-06-30 |
| Wellington Management Group LLP | 3.52M | $115.0M | 5.64% | +423.6K | 2026-06-30 |
| Morgan Stanley | 3.45M | $112.0M | 5.53% | +29.5K | 2026-06-30 |
| Baker Bros. Advisors LP | 3.34M | $109.0M | 5.35% | -- | 2026-06-30 |
| Toronto Dominion Bank | 3.17M | $103.0M | 5.09% | -- | 2026-06-30 |
| State Street Corp | 2.85M | $93.0M | 4.57% | +575.7K | 2026-06-30 |